India  
 
NewsR.in

Novartis set to divest Indian eyecare portfolio to JB Chemicals

IndiaTimes Sunday, 10 December 2023
Novartis plans to divest its Indian eyecare portfolio to JB Chemicals, adding to the list of MNCs reducing exposure to the Indian market. The move aligns with Novartis' strategy to capitalize on ophthalmic therapy while offering JB Chemicals entry into a growing business segment. Global Big Pharma has been divesting branded generics to Indian companies, while Indian players are diversifying from the US generics market. The deal is expected to be announced soon. The demand for eyecare is increasing due to the ageing population and greater access, driven by the use of tablets and mobile devices.
0
shares		ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

WFI Suspension: Centre Asks Indian Olympic Association To Form Temporary Committee | Oneindia News [Video]

WFI Suspension: Centre Asks Indian Olympic Association To Form Temporary Committee | Oneindia News

In a surprising move, the Indian government directs the Indian Olympic Association to establish a panel to oversee the national wrestling body. Discover the details behind this intervention, its impact..

Credit: Oneindia     Duration: 03:28Published